FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma
Perioperative novel systemic immunotherapy-based approaches in urinary cancers
Conducting Oncology Clinical Trials in Africa II: Practical steps for conducting clinical trials in Africa
Ensuring quality care for breast cancer patients globally
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)
Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma
Better genetic diagnostics in Ugandan breast cancer patients
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic
The COVID-19 and Cancer Consortium
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer